ReviewCancer drug resistance (Alhambra, Calif.)2021

Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a review.

Shogo Ozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.